Literature DB >> 32961557

Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records.

Ky'Era V Actkins1,2, Kritika Singh2,3, Donald Hucks2,3, Digna R Velez Edwards2,4,5, Melinda Aldrich2,3,6,7, Jeeyeon Cha8, Melissa Wellons8, Lea K Davis2,3,7.   

Abstract

CONTEXT: Polycystic ovary syndrome (PCOS) is one of the leading causes of infertility, yet current diagnostic criteria are ineffective at identifying patients whose symptoms reside outside strict diagnostic criteria. As a result, PCOS is underdiagnosed and its etiology is poorly understood.
OBJECTIVE: We aim to characterize the phenotypic spectrum of PCOS clinical features within and across racial and ethnic groups.
METHODS: We developed a strictly defined PCOS algorithm (PCOSkeyword-strict) using the International Classification of Diseases, ninth and tenth revisions and keywords mined from clinical notes in electronic health records (EHRs) data. We then systematically relaxed the inclusion criteria to evaluate the change in epidemiological and genetic associations resulting in 3 subsequent algorithms (PCOScoded-broad, PCOScoded-strict, and PCOSkeyword-broad). We evaluated the performance of each phenotyping approach and characterized prominent clinical features observed in racially and ethnically diverse PCOS patients.
RESULTS: The best performance came from the PCOScoded-strict algorithm, with a positive predictive value of 98%. Individuals classified as cases by this algorithm had significantly higher body mass index (BMI), insulin levels, free testosterone values, and genetic risk scores for PCOS, compared to controls. Median BMI was higher in African American females with PCOS compared to White and Hispanic females with PCOS.
CONCLUSIONS: PCOS symptoms are observed across a severity spectrum that parallels the continuous genetic liability to PCOS in the general population. Racial and ethnic group differences exist in PCOS symptomology and metabolic health across different phenotyping strategies. © Endocrine Society 2020.

Entities:  

Keywords:  electronic health record; hormones; phenotyping; polycystic ovary syndrome; polygenic risk scores

Mesh:

Year:  2021        PMID: 32961557      PMCID: PMC7765638          DOI: 10.1210/clinem/dgaa675

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  43 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

Review 2.  Racial and ethnic disparities in reproductive endocrinology and infertility.

Authors:  Heather G Huddleston; Marcelle I Cedars; Sae H Sohn; Linda C Giudice; Victor Y Fujimoto
Journal:  Am J Obstet Gynecol       Date:  2010-03-06       Impact factor: 8.661

3.  Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Marina A Skiba; Rakibul M Islam; Robin J Bell; Susan R Davis
Journal:  Hum Reprod Update       Date:  2018-11-01       Impact factor: 15.610

4.  A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies.

Authors:  Yoonjung Yoonie Joo; Ky'Era Actkins; Jennifer A Pacheco; Anna O Basile; Robert Carroll; David R Crosslin; Felix Day; Joshua C Denny; Digna R Velez Edwards; Hakon Hakonarson; John B Harley; Scott J Hebbring; Kevin Ho; Gail P Jarvik; Michelle Jones; Tugce Karaderi; Frank D Mentch; Cindy Meun; Bahram Namjou; Sarah Pendergrass; Marylyn D Ritchie; Ian B Stanaway; Margrit Urbanek; Theresa L Walunas; Maureen Smith; Rex L Chisholm; Abel N Kho; Lea Davis; M Geoffrey Hayes
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

5.  Defining Phenotypes from Clinical Data to Drive Genomic Research.

Authors:  Jamie R Robinson; Wei-Qi Wei; Dan M Roden; Joshua C Denny
Journal:  Annu Rev Biomed Data Sci       Date:  2018-04-25

Review 6.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

7.  Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

Authors:  Nigel K Stepto; Samantha Cassar; Anju E Joham; Samantha K Hutchison; Cheryce L Harrison; Rebecca F Goldstein; Helena J Teede
Journal:  Hum Reprod       Date:  2013-01-12       Impact factor: 6.918

8.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

9.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

Authors:  Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies
Journal:  Hum Reprod       Date:  2009-11-12       Impact factor: 6.918

Review 10.  Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women.

Authors:  Dinka Pavicic Baldani; Lana Skrgatic; Roya Ougouag
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

View more
  4 in total

1.  The efficacy and safety of metformin combined with simvastatin in the treatment of polycystic ovary syndrome: A meta-analysis and systematic review.

Authors:  Yanbo Liu; Yupei Shao; Jiping Xie; Linlin Chen; Guang Zhu
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

2.  Fully exploiting SNP arrays: a systematic review on the tools to extract underlying genomic structure.

Authors:  Laura Balagué-Dobón; Alejandro Cáceres; Juan R González
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

3.  "I felt like she didn't take me seriously": a multi-methods study examining patient satisfaction and experiences with polycystic ovary syndrome (PCOS) in Canada.

Authors:  Miya Ismayilova; Sanni Yaya
Journal:  BMC Womens Health       Date:  2022-02-23       Impact factor: 2.809

4.  Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records.

Authors:  Ky'Era V Actkins; Kritika Singh; Donald Hucks; Digna R Velez Edwards; Melinda Aldrich; Jeeyeon Cha; Melissa Wellons; Lea K Davis
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.